氨基酸schiff碱及其金属配合物的性能研究进展

氨基酸Sch iff碱及其金属配合物具有良好的抗炎、抗菌、抗癌等生物活性而有望成为高效、低毒、可供临床使用的新药物而引起人们的极大关注。本文综述了氨基酸sch iff碱及其金属配合物的生物活性、测定金属含量、催化、载氧等性能的研究情况(特别是在生物活性方面),并分析总结了其在研究方面存在的问题。     

几种氨基酸Schiff碱的合成及抑菌活性

合成了三种氨基酸Ｓｃｈｉｆｆ碱,其化学组成由红外光谱、元素分析等证实,并对它们进行了抑菌活性测试。     

氨基酸Schiff碱金属配合物的研究进展

本文概述了近年来国内外在氨基酸Ｓｃｈｉｆ碱金属配合物领域的研究进展。简介了它们的合成方法和在金属离子分析、药物化学、生物模拟、氨基酸的合成及拆分上的应用。     

L—亮氨酸Schiff碱的锌（Ⅱ）配合物的合成及抑菌活性

本文合成了尚未见报道的Ｌ—亮氨酸Ｓｃｈｉｆｆ碱的锌（Ⅱ）配合物,并进行了性质表征和抑菌活性实验。     

氨基酸Shiff碱金属配合物的研究进展

本文概述了近年来国内外在氨基酸Ｓｃｈｉｆｆ碱金属配合物的研究进展,简介了它们的合成方法和在金属离子分析、药物化学、生物模拟、氨基酸的合成及拆分上的应用 。     

L－亮氨酸Schiff碱Cu（Ⅱ）、Ni（Ⅱ）配合物的合成及抑菌活性

合成了Ｌ－亮氨酸Ｓｃｈｉｆｆ碱的Ｃｕ（Ⅱ）、Ｎｉ（Ⅱ）配合物,其化学结构由红外光谱、元素分析、热重分析及摩尔电导等证实。对配合物进行了抑菌测试。     

L－亮氨酸Schiff碱Cu（Ⅱ）、Ni（Ⅱ）配合物的合成及抑菌活性

合成了Ｌ－亮氨酸Ｓｃｈｉｆｆ碱的Ｃｕ（Ⅱ）、Ｎｉ（Ⅱ）配合物,其化学结构由红外光谱、元素分析、热重分析及摩尔电导等证实。对配合物进行了抑菌测试。     

聚球藻类金属硫蛋白的纯化及部分性质的研究

单细胞蓝藻（Ｓｙｎｅｃｈｏｃｏｃｕｓｓｐ．ＰＣＣ７９４２）以５０μｍｏｌ／ＬＺｎ２＋诱导８ｄ后收集,破碎取上清液经凝胶过滤、离子交换层析及反相ＨＰＬＣ纯化得到类金属硫蛋白,产率为每升培养液收集１．５ｇ鲜藻,得２．５ｍｇ纯品．其单体分子量为８７５０,Ｎ未端测定为缬氨酸,氨基酸组成分析得每分子（５６个氨基酸）含１０个半胱氨酸,疏水氨酸较多,且含有芳香族氨基酸,原子吸收光谱测得每分子蛋白结合４个二价金属．以上表明,该种类金属硫蛋白与哺乳动物金属硫蛋白结构差异很大,可能只是一种进化上的趋同．     

短距乌头根的两个新二萜生物碱

从短距乌头（Ａｃｏｎｉｔｕｍ ｂｒｅｖｉｃａｌｃａｒａｔｕｍ Ｄｉｅｌｓ）的根分离到两个新的二萜生物碱：短距乌碱丁（ａｃｏｂｒｅｔｉｎｅ Ｄ, Ⅰ）和短距乌碱戊（ａｃｏｂｒｅｔｉｎｅ Ｅ, Ⅱ）,通过光谱技术（ＩＲ, ＭＳ, １Ｈ 和１３Ｃ－ＮＭＲ）和化学方法确定了它们的结构。短距乌碱丁最初以盐酸盐的形式分得,利用１Ｈ－１ＨＣＯＳＹ 和１３Ｃ－１Ｈ ＣＯＳＹ 归属了其盐的各碳和氢的化学位移值     

大花地不容中的生物碱

大花地不容（ＳｔｅｐｈａｎｉａｍａｃｒａｎｔｈａＨ．Ｓ．ＬｏｅｔＭ．Ｙａｎｇ）系防己科千金藤属（Ｓｔｅｐｈａ－ｎｉａ）一新种［１］。其化学成分未见报道。今从其块根中分得８种生物碱,经鉴定,主要为ｌ－四氢巴马汀（ｌ－ｔｅｔｒａｈｙｄｒｏｐａｌｍａｔｉｎｅ,Ⅰ）和异紫堇定碱（ｉｓｏｃｏｒｙｄｉｎｅ,Ⅱ）,得率分别为０．８３％和１．８２％。其余为紫堇定碱（ｃｏｒｙｄｉｎｅ,Ⅲ）、紫堇单酚碱（ｃｏｒｙｄａｌｍｉｎｅ,Ⅳ）、千金藤定碱（ｓｔｅｐｈａｌｉｄｉｎｅ,Ⅴ）、巴马汀碱（ｐａｌｍａｔｉｎｅ,Ⅵ）、紫…     

Antimicrobial, spectral, magnetic and thermal studies of Cu(II), Ni(II), Co(II), UO(2)(VI) and Fe(III) complexes of the Schiff base derived from oxalylhydrazide

The Schiff base ligand, oxalic bis[(2-hydroxybenzylidene)hydrazide], H(2)L, and its Cu(II), Ni(II), Co(II), UO(2)(VI) and Fe(III) complexes were prepared and tested as antibacterial agents. The Schiff base acts as a dibasic tetra- or hexadentate ligand with metal cations in molar ratio 1:1 or 2:1 (M:L) to yield either mono- or binuclear complexes, respectively. The ligand and its metal complexes were characterized by elemental analyses, IR, (1)H NMR, Mass, and UV-Visible spectra and the magnetic moments and electrical conductance of the complexes were also determined. For binuclear complexes, the magnetic moments are quite low compared to the calculated value for two metal ions complexes and this shows antiferromagnetic interactions between the two adjacent metal ions. The ligand and its metal complexes were tested against a Gram + ve bacteria (Staphylococcus aureus), a Gram -ve bacteria (Escherichia coli), and a fungi (Candida albicans). The tested compounds exhibited high antibacterial activities.     

CONVERSION OF TRYPSIN TO A COPPER ENZYME: TYROSINASE/CATECHOL OXIDASE BY CHEMICAL MODIFICATION

New active sites can be introduced into naturally occurring enzymes by the chemical modification of specific amino acid residues in concert with genetic techniques. Chemical strategies have had a significant impact in the field of enzyme design such as modifying the selectivity and catalytic activity which is very different from those of the corresponding native enzymes. Thus, chemical modification has been exploited for the incorporation of active site binding analogs onto protein templates and for atom replacement in order to generate new functionality such as the conversion of a hydrolase into a peroxidase. The introduction of a coordination complex into a substrate binding pocket of trypsin could probably also be extended to various enzymes of significant therapeutic and biotechnological importance.

The aim of this study is the conversion of trypsin into a copper enzyme: tyrosinase by chemical modification. Tyrosinase is a biocatalyst (EC.1.14.18.1) containing two atoms of copper per active site with monooxygenase activity. The active site of trypsin (EC 3.4.21.4), a serine protease was chemically modified by copper (Cu⁺²) introduced p-aminobenzamidine (pABA- Cu⁺²: guanidine containing schiff base metal chelate) which exhibits affinity for the carboxylate group in the active site as trypsin-like inhibitor. Trypsin and the resultant semisynthetic enzyme preparation was analysed by means of its trypsin and catechol oxidase/tyrosinase activity. After chemical modification, trypsin-pABA-Cu⁺² preparation lost 63% of its trypsin activity and gained tyrosinase/catechol oxidase activity. The kinetic properties (K_cat, K_m, K_cat/K_m), optimum pH and temperature of the trypsin-pABA-Cu⁺² complex was also investigated.     

Antimicrobial,spectral, magnetic and thermal studies of Cu(II), Ni(II), Co(II), UO2(VI) and Fe(III) complexes of the Schiff base derived from oxalylhydrazide

The Schiff base ligand, oxalic bis[(2-hydroxybenzylidene)hydrazide], H₂L, and its Cu(II), Ni(II), Co(II), UO₂(VI) and Fe(III) complexes were prepared and tested as antibacterial agents. The Schiff base acts as a dibasic tetra- or hexadentate ligand with metal cations in molar ratio 1:1 or 2:1 (M:L) to yield either mono- or binuclear complexes, respectively. The ligand and its metal complexes were characterized by elemental analyses, IR, ¹H NMR, Mass, and UV-Visible spectra and the magnetic moments and electrical conductance of the complexes were also determined. For binuclear complexes, the magnetic moments are quite low compared to the calculated value for two metal ions complexes and this shows antiferromagnetic interactions between the two adjacent metal ions. The ligand and its metal complexes were tested against a Gram + ve bacteria (Staphylococcus aureus), a Gram -ve bacteria (Escherichia coli), and a fungi (Candida albicans). The tested compounds exhibited high antibacterial activities.     

Synthesis of aminobenzyltriethylenetetraaminohexaacetic acid: conjugation of the chelator to protein by an alkylamine linkage

The conjugation of a chelating agent to an antibody as an anchoring site for a radionuclide is the first step in the successful preparation of a radiolabeled antibody for a diagnostic and therapeutic application. The high affinity of the protein bound chelator towards radionuclide ensures a higher selectivity in the delivery of the radionuclide to the targeted tissue. 4-Aminobenzylderivativetriethlenetetraaminohexaacetic acid (TTHA), a hexadentate chelating agent has been now prepared for conjugation with proteins in view of the higher affinity of TTHA metal ions as compared to DTPA. The latent crosslinking potential of -hydroxy aldehydes has been used to conjugate the new chelating agent to proteins through an alkylamine linkage. On incubation of amino benzyl TTHA with glycoladehyde at neutral pH and room temperature, the reagent is converted to oxoethyl amino benzyl TTHA. On addition of albumin to this reaction mixture, the oxo ethylamino benzyl TTHA generates reversible schiff base adducts with the amino groups of albumin. The reduction of the Schiff base adducts of the chelator with the protein by sodium cyanoborohydride stabilizes the schiff base adducts as stable alkylamine linkages. 4-Thiocyanatobenzyl TTHA has also been prepared and conjugated to albumin through a thiocarbamoyl linkage. Both preparations of TTHA conjugated albumin complexed with ^99mTc and ¹¹¹In, with high affinity and no decomposition of the complex was noticed for at least up to 6 hrs after the preparation. The radiolabels complexed with these TTHA -albumin conjugates could not be chased out by free DTPA. A comparison of the biodistribution of ¹¹¹In, bound to the TTHA conjugated through an alkylamine and a thiocarbamoyl linkage showed that ¹¹¹In complexed with alkylamine linked TTHA was retained in blood to a level nearly 17% higher compared to that seen with thicarbamoyl linked TTHA, one hr after the injection into mice. Thus, the alkylamine linkage appears to be more stable under the in vivo conditions. The glycolaldehyde mediated alkylation procedure offers a mild, simple and rapid method for preparation of drug-protein (antibody) conjugates.     

Synthesis and study of physico-chemical properties of a new chiral Schiff base ligand and its metal complex

A new chiral amino acid Schiff base ligand (Salarg) and its metal complex (Mn-Salarg) have been synthesized using l-Arginine, a naturally occurring chiral diamine with two kinds of asymmetric α-, ε-NH₂ groups. This new Salarg-ligand and Mn-Salarg complex are characterized with the help of ultraviolet, fluorescence and infrared spectroscopy. Their crystal systems are determined by X-ray powder diffraction method. The elemental analysis has been carried out by energy dispersive X-ray analysis (EDAX). The presence and percentage of metal in the complex have been detected and estimated by energy dispersive X-ray fluorescence (EDXRF) spectroscopy. Circular dichroism spectroscopy has revealed the chiral nature of the Salarg-ligand and its metal complex. Furthermore, a comparative study of this new chiral Salarg-ligand and its complex has been made with the well known achiral Salen ligand and its metal complex (Mn-Salen).     

Protective role of a coumarin-derived schiff base scaffold against tertiary butyl hydroperoxide (TBHP)-induced oxidative impairment and cell death via MAPKs, NF-κB and mitochondria-dependent pathways

The present study investigated the antioxidant signalling mechanism of a coumarin-derived schiff base (CSB) scaffold against tert-butylhydroperoxide (TBHP) induced oxidative insult in murine hepatocytes. CSB possesses DPPH and other free radical scavenging activities. TBHP reduced cell viability and intracellular antioxidant status accompanied by an increase in intracellular ROS production in hepatocytes. TBHP also activated phospho-ERK1/2, phospho-p38 and NF-κB, altered the Bcl-2/Bad ratio, reduced mitochondrial membrane potential, released cytochrome C and activated caspase 3, suggesting that TBHP induced oxidative stress responsive cell death via apoptotic pathway. FACS analysis and DNA fragmentation studies also confirmed the apoptotic cell death in TBHP exposed hepatocytes. Treatment with CSB effectively reduced these adverse effects by preventing the oxidative insult, alteration in the redox-sensitive signalling cascades and mitochondrial events. Combining, results suggest that antioxidant property of CSB make the molecule to be a potential protective measure against oxidative insult, cytotoxicity and cell death.     

Extraordinary rates of transition metal ion-mediated ribozyme catalysis

In pre-steady-state, fast-quench kinetic analysis, the tertiary-stabilized hammerhead ribozyme "RzB" cleaves its substrate RNA with maximal measured k (obs) values of approximately 3000 min(-1) in 1 mM Mn(2+) and approximately 780 min(-1) in 1 mM Mg(2+) at 37 degrees C (pH 7.4). Apparent pKa for the catalytic general base is approximately 7.8-8.5, independent of the corresponding metal hydrate pKa, suggesting potential involvement of a nucleobase as general base as suggested previously from nucleobase substitution studies. The pH-rate profile is bell-shaped for Cd(2+), for which the general catalytic acid has a pKa of 7.3 +/- 0.1. Simulations of the pH-rate relation suggest a pKa for the general catalytic acid to be approximately 9.5 in Mn(2+) and >9.5 in Mg(2+). The acid pKa's follow the trend in the pKa of the hydrated metal ions but are displaced by approximately 1-2 pH units in the presence of Cd(2+) and Mn(2+). One possible explanation for this trend is direct metal ion coordination with a nucleobase, which then acts as general acid.     

Protective role of a coumarin-derived schiff base scaffold against tertiary butyl hydroperoxide (TBHP)-induced oxidative impairment and cell death via MAPKs,NF-κB and mitochondria-dependent pathways

Abstract

The present study investigated the antioxidant signalling mechanism of a coumarin-derived schiff base (CSB) scaffold against tert-butylhydroperoxide (TBHP) induced oxidative insult in murine hepatocytes. CSB possesses DPPH and other free radical scavenging activities. TBHP reduced cell viability and intracellular antioxidant status accompanied by an increase in intracellular ROS production in hepatocytes. TBHP also activated phospho-ERK1/2, phospho-p38 and NF-κB, altered the Bcl-2/Bad ratio, reduced mitochondrial membrane potential, released cytochrome C and activated caspase 3, suggesting that TBHP induced oxidative stress responsive cell death via apoptotic pathway. FACS analysis and DNA fragmentation studies also confirmed the apoptotic cell death in TBHP exposed hepatocytes. Treatment with CSB effectively reduced these adverse effects by preventing the oxidative insult, alteration in the redox-sensitive signalling cascades and mitochondrial events. Combining, results suggest that antioxidant property of CSB make the molecule to be a potential protective measure against oxidative insult, cytotoxicity and cell death.